Consolidated Profitability Improvement
GAAP net income of $0.3 million ($0.02 per diluted share) vs. a net loss of $1.4 million (−$0.12) in the prior year; non‑GAAP net income of $1.3 million ($0.11 per diluted share) vs. $0.8 million ($0.06) prior year.
Strong Cash Position and No Debt
Cash on hand of $33.6 million as of March 31, 2026, no bank debt outstanding, and $21.3 million available under the revolving credit facility.
Historic High New Bookings Momentum in Data & AI
Data & AI new bookings of $7.0 million TCV in the quarter vs. $3.7 million TCV a year ago (≈+89% YoY in new bookings); total Q1 bookings $13.6 million TCV (vs. $15.3 million prior year).
Edge Initiative Delivering Efficiency Gains
EDGE efficiency phase reported as delivered; efficiencies captured in Q1 are being redeployed into investments (AI engineering, modern data platforms, go-to-market), enabling the shift from cost savings to growth investments.
Average Bill Rate at Company High
Average bill rate reached $90.91, up from $87.82 a year ago (≈+3.5%), reflecting deliberate focus on revenue quality and higher‑margin engagements.
Strategic Enterprise Win — Healthcare
Won a multiyear, multimillion‑dollar engagement with a leading healthcare payer to build an AI‑ready data platform and advanced analytics capabilities; management cited this as an example of cross‑sell and integrated Data & AI success and it is included in Q1 bookings.
Corporate Actions and Governance Flexibility
Board authorized a new share repurchase program up to $5 million (effective Feb 16, 2026); full authorization remains available as no repurchases were made in Q1.